Recombinant human monoclonal antibodies

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cell Biophysics

• Publication date

  1992-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02789480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of a human IgM expression library in E. coli

  1992cited by this paper
• A vector for the removal of deletion mutants from antibody libraries.

  1992cited by this paper
• Humanization of immunotoxins.

  1992cited by this paper
• Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem.

  1992cited by this paper
• Regulated secretion and purification of recombinant antibodies inE. coli

  1992cited by this paper
• Preparation and characterization of a beta-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents.

  1992cited by this paper
• Man-made antibodies

  1991cited by this paper
• A surface expression vector for antibody screening.

  1991cited by this paper
• Metal affinity precipitation of proteins carrying genetically attached polyhistidine affinity tails.

  1991cited by this paper
• Targeting Recombinant Antibodies to the Surface of Escherichia coli: Fusion to a Peptidoglycan Associated Lipoprotein

  1991cited by this paper
• Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.

  1991cited by this paper
• Preliminary trial of specific targeting therapy against malignant glioma.

  1990cited by this paper
• A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

  1989cited by this paper
• Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

  1988cited by this paper
• A cytotoxic agent can be generated selectively at cancer sites.

  1988cited by this paper
• Assembly of a functional immunoglobulin Fv fragment in Escherichia coli.

  1988cited by this paper
• Escherichia coli secretion of an active chimeric antibody fragment.

  1988cited by this paper
• Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.

  1986cited by this paper
• Carboxy-terminal regions on the surface of tubulin and microtubules. Epitope locations of YOL1/34, DM1A and DM1B.

  1986cited by this paper
• Purification of proteins by IMAC

  1985cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper
• Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

  1983cited by this paper
• Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line

  1982cited by this paper

• N-Glycans Modulate HIV-1 Env Conformational Plasticity

  2025cites this paper
• Evolution of Bioaffinity Reagents by Phage Display

  2010cites this paper
• Enhancing phage display of antibody fragments using gIII-amber suppression.

  2007cites this paper
• A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells

  2006cites this paper
• A new generation of monoclonal and recombinant antibodies against cell‐adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer

  2006cites this paper
• AntibodiesAgainst Cell-Adherent Prostate Specific MembraneAntigen forDiagnostic andTherapeutic Targetingof ProstateCancer

  2006cites this paper
• Regulated secretion and purification of recombinant antibodies inE. coli

  1992cites this paper